Cancer remains one of the leading causes of mortality worldwide, with millions diagnosed each year. As medical science advances, the landscape of cancer treatment continues to evolve, offering new hope to patients. Among the significant breakthroughs in targeted therapies, Gefitinib, an epidermal growth factor receptor (EGFR) inhibitor, has emerged as a transformative treatment option,...
0 Commentarios
0 Acciones
212 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek